世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

移植市場の規模、シェア、動向分析レポート：製品別（組織製品、免疫抑制剤、保存液）、用途別（臓器、組織移植）、エンドユーザー別、セグメント別予測、2022年〜2030年


Transplantation Market Size, Share, & Trends Analysis Report By Product (Tissue Products, Immunosuppressive Drugs, Preservation Solution), By Application (Organ, Tissue Transplant), By End Use, And Segment Forecasts, 2022 - 2030

移植市場の成長とトレンド グランドビューリサーチ社の最新レポートによると、世界の移植市場規模は2030年までに309億ドルに達し、CAGR9.4％で拡大すると予測されています。臓器不全の発生率が高まっているこ... もっと見る

　

　

出版社 出版年月 電子版価格 ページ数 言語
Grand View Research
グランドビューリサーチ 		2022年4月12日 US$5,950
シングルユーザーライセンス
ライセンス・価格情報
注文方法はこちら 		110 英語

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


　

サマリー

移植市場の成長とトレンド

グランドビューリサーチ社の最新レポートによると、世界の移植市場規模は2030年までに309億ドルに達し、CAGR9.4％で拡大すると予測されています。臓器不全の発生率が高まっていることが、移植市場の大幅な成長をもたらしています。

組織製品、免疫抑制剤、臓器保存ソリューションなどの移植製品に対する需要の高まりは、予測期間中の市場成長を後押しする主な要因となっています。このため、多くのバイオテクノロジー企業や医療機器企業が、臓器不全の管理に使用する高度な移植製品の開発に力を入れ始めています。

臓器移植法の技術的進歩も、市場の成長を支える主要な要因の一つです。組織製品や手術器具など、新規かつ改良された移植製品の開発は、この分野の拡大に大きく寄与しています。

また、DeNovo NT Graft、Chondrofix Osteochondral Allograft、DuraMatrix Collagen Dura Substitute Membraneなどの高度な組織製品の導入は、治療中に高い利益をもたらします。また、高度なシステムとソフトウェアによるコンピュータ支援システムにより、組織のメンテナンスが容易かつ効果的に行えるようになりました。このように、高度な技術が臓器移植の普及を支えています。

臓器移植市場レポートハイライト

- 組織や臓器の移植手術数の増加により、組織製品部門が最大の売上高を記録

- 移植用製品の進歩により、組織製品分野は最も高いCAGRで成長すると予想される

- 皮膚、骨、心臓弁、角膜、腱、神経、静脈などの移植手術が世界的に増加していることから、組織移植分野が最大の売上高を占めている

- 移植手術のための移植センターの人気が高まっていることから、予測期間中に最も高いCAGRで拡大すると予測される

- 病院で行われる移植手術の数が多いことから、2021年の売上高は病院セグメントが圧倒的であった

- 2021年の地域別売上では北米がトップであり、医療インフラの充実により予測期間中も優位性を維持すると予測される

- 北米地域には多数の研究所、バイオテクノロジー、医療機器企業が存在することが大きなシェア要因

ページTOPに戻る


目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product type
1.1.2. Application type
1.1.3. End use
1.1.4. Region scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product type outlook
2.2.2. Application type outlook
2.2.3. End use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Transplantation Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Increasing incidence of organ failure
3.4.1.2. Technological advancement in transplantation method
3.4.1.3. Developed tissue banks
3.4.2. Market restraint analysis
3.4.2.1. Shortage of organ donors
3.4.2.2. Ethical and cultural issues
3.4.3. Key opportunities prioritized
3.4.3.1. Key opportunities prioritized, by Product
3.4.3.2. Key opportunities prioritized, by application
3.4.3.3. Key opportunities prioritized, by end use
3.5. Transplantation Market Analysis Tools
3.5.1. Industry analysis - Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major deals & strategic alliances analysis
3.5.4. Market entry strategies
Chapter 4. Transplantation Market by Product Type Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Tissue products
4.1.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
4.1.2. Immunosuppressive drugs
4.1.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
4.1.3. Preservation Solutions
4.1.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
Chapter 5. Transplantation Market: Application Type Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Organ transplant
5.1.2. Tissue transplant
5.2. Product Market Share, 2021 & 2030
5.3. Segment Dashboard
5.4. Global Transplantation Market by Application Type Outlook
5.4.1. Organ transplant
5.4.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.4.2. Tissue transplant
5.4.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
Chapter 6. Transplantation Market: End-Use Estimates & Trend Analysis
6.1. Definitions and Scope
6.1.1. Hospitals
6.1.2. Transplantation centers
6.1.3. Others
6.2. Product Market Share, 2021 & 2030
6.3. Segment Dashboard
6.4. Global Transplantation MarEnd-UseEnd Use Channel Outlook
6.4.1. Hospitals
6.4.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.4.2. Transplantation centers
6.4.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.4.3. Others
6.4.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
Chapter 7. Transplantation Market: Country Estimates & Trend Analysis
7.1. Country Market Share Analysis, 2021 & 2030
7.2. County Market Dashboard
7.3. Regional Market Snapshot
7.4. Regional Market Share and Leading Players, 2021
7.4.1. North America
7.4.2. Europe
7.4.3. Asia Pacific
7.4.4. Latin America
7.4.5. Middle East and Africa
7.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
7.5.1. North America
7.5.2. Europe
7.5.3. Asia Pacific
7.5.4. Latin America
7.5.5. Middle East and Africa
7.6. Market Size, & Forecasts, Volume and Trend Analysis, 2021 to 2030:
7.7. North America
7.7.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.7.2. U.S.
7.7.2.1. U.S. market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.7.3. Canada
7.7.3.1. Canada market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.8. Europe
7.8.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.8.2. U.K.
7.8.2.1. U.K. market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.8.3. Germany
7.8.3.1. Germany market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.8.4. France
7.8.4.1. France market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.8.5. Italy
7.8.5.1. Italy market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.8.6. Spain
7.8.6.1. Spain market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.9. Asia Pacific
7.9.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.9.2. Japan
7.9.2.1. Japan market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.9.3. China
7.9.3.1. China market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.9.4. India
7.9.4.1. India market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.10. Latin America
7.10.1. market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.10.2. Brazil
7.10.2.1. Brazil market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.10.3. Mexico
7.10.3.1. Mexico market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.11. Middle East & Africa
7.11.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.11.2. South Africa
7.11.2.1. South Africa market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.11.3. Saudi Arabia
7.11.3.1. South Africa market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.2.1. Innovators
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2021
8.3.4. Stryker Corporation
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Procedure benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Medtronic
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Procedure benchmarking
8.3.5.4. Strategic initiatives
8.3.6. AbbVie Inc.
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Procedure benchmarking
8.3.6.4. Strategic initiatives
8.3.7. Zimmer Biomet
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Procedure benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Novartis
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Procedure benchmarking
8.3.8.4. Strategic initiatives
8.3.9. 21 st Century Medicine
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Procedure benchmarking
8.3.9.4. Strategic initiatives
8.3.10. Biolife Solutions
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Procedure benchmarking
8.3.10.4. Strategic initiatives
8.3.11. Teva Pharmaceutical
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Procedure benchmarking
8.3.11.4. Strategic initiatives
8.3.12. Veloxis Pharmaceuticals
8.3.12.1. Company overview
8.3.12.2. Financial performance
8.3.12.3. Procedure benchmarking
8.3.12.4. Strategic initiatives


　

ページTOPに戻る


　

Summary

Transplantation Market Growth & Trends

The global transplantation market size is expected to reach USD 30.9 billion by the year 2030, expanding at a CAGR of 9.4%, according to a new report by Grand View Research, Inc. Growing incidence of organ failure has resulted in massive growth in the transplantation market.

Rising demand for transplant products such as tissue products, immunosuppressants, and organ preservation solutions is a major factor anticipated to boost the market’s growth during the forecast period. Thus, many biotechnology and medical device companies have begun to concentrate on the development of advanced transplant products for the management of organ failure.

Technological advancement in organ transplantation methods is another major factor supporting the market growth. The development of novel & improved transplant products such as tissue products and surgical instruments has majorly contributed to the expansion of the sector.

In addition, the introduction of advanced tissue products such as DeNovo NT Graft, Chondrofix Osteochondral Allograft, and DuraMatrix Collagen Dura Substitute Membrane provides higher benefits during treatment. In addition, computerized support systems with advanced systems and software allow easy & effective maintenance of tissues. Thus, the availability of such advanced techniques supports an increase in the number of organ transplant procedures.

Transplantation Market Report Highlights

• Tissue products segment was the largest revenue-generating amongst others due to escalating number of tissue and organ transplant procedures

• Tissue products segment is also expected to rise at the highest CAGR owing to advancements in transplantation products

• Tissue transplant segment held the largest revenue share in the market, because of the rising number of skin, bones, heart valves, cornea, tendons, nerves, and veins procedures worldwide

• The transplant centers segment is projected to expand at the highest CAGR during the forecast period owing to rising popularity of these centers for transplant procedures

• The hospitals segment dominated the market in terms of revenue in 2021 owing to a large number of transplant procedures performed in hospitals

• North America was the leading regional sector in 2021 and is projected to maintain its dominance during the forecast period owing to well-developed healthcare infrastructure

• Existence of a large number of research laboratories, biotechnology, and medical device companies in the North America region is the major factor contributing to its large share



ページTOPに戻る


Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product type
1.1.2. Application type
1.1.3. End use
1.1.4. Region scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product type outlook
2.2.2. Application type outlook
2.2.3. End use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Transplantation Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Increasing incidence of organ failure
3.4.1.2. Technological advancement in transplantation method
3.4.1.3. Developed tissue banks
3.4.2. Market restraint analysis
3.4.2.1. Shortage of organ donors
3.4.2.2. Ethical and cultural issues
3.4.3. Key opportunities prioritized
3.4.3.1. Key opportunities prioritized, by Product
3.4.3.2. Key opportunities prioritized, by application
3.4.3.3. Key opportunities prioritized, by end use
3.5. Transplantation Market Analysis Tools
3.5.1. Industry analysis - Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major deals & strategic alliances analysis
3.5.4. Market entry strategies
Chapter 4. Transplantation Market by Product Type Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Tissue products
4.1.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
4.1.2. Immunosuppressive drugs
4.1.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
4.1.3. Preservation Solutions
4.1.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
Chapter 5. Transplantation Market: Application Type Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Organ transplant
5.1.2. Tissue transplant
5.2. Product Market Share, 2021 & 2030
5.3. Segment Dashboard
5.4. Global Transplantation Market by Application Type Outlook
5.4.1. Organ transplant
5.4.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.4.2. Tissue transplant
5.4.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
Chapter 6. Transplantation Market: End-Use Estimates & Trend Analysis
6.1. Definitions and Scope
6.1.1. Hospitals
6.1.2. Transplantation centers
6.1.3. Others
6.2. Product Market Share, 2021 & 2030
6.3. Segment Dashboard
6.4. Global Transplantation MarEnd-UseEnd Use Channel Outlook
6.4.1. Hospitals
6.4.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.4.2. Transplantation centers
6.4.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.4.3. Others
6.4.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
Chapter 7. Transplantation Market: Country Estimates & Trend Analysis
7.1. Country Market Share Analysis, 2021 & 2030
7.2. County Market Dashboard
7.3. Regional Market Snapshot
7.4. Regional Market Share and Leading Players, 2021
7.4.1. North America
7.4.2. Europe
7.4.3. Asia Pacific
7.4.4. Latin America
7.4.5. Middle East and Africa
7.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
7.5.1. North America
7.5.2. Europe
7.5.3. Asia Pacific
7.5.4. Latin America
7.5.5. Middle East and Africa
7.6. Market Size, & Forecasts, Volume and Trend Analysis, 2021 to 2030:
7.7. North America
7.7.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.7.2. U.S.
7.7.2.1. U.S. market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.7.3. Canada
7.7.3.1. Canada market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.8. Europe
7.8.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.8.2. U.K.
7.8.2.1. U.K. market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.8.3. Germany
7.8.3.1. Germany market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.8.4. France
7.8.4.1. France market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.8.5. Italy
7.8.5.1. Italy market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.8.6. Spain
7.8.6.1. Spain market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.9. Asia Pacific
7.9.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.9.2. Japan
7.9.2.1. Japan market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.9.3. China
7.9.3.1. China market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.9.4. India
7.9.4.1. India market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.10. Latin America
7.10.1. market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.10.2. Brazil
7.10.2.1. Brazil market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.10.3. Mexico
7.10.3.1. Mexico market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.11. Middle East & Africa
7.11.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.11.2. South Africa
7.11.2.1. South Africa market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.11.3. Saudi Arabia
7.11.3.1. South Africa market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.2.1. Innovators
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2021
8.3.4. Stryker Corporation
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Procedure benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Medtronic
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Procedure benchmarking
8.3.5.4. Strategic initiatives
8.3.6. AbbVie Inc.
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Procedure benchmarking
8.3.6.4. Strategic initiatives
8.3.7. Zimmer Biomet
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Procedure benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Novartis
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Procedure benchmarking
8.3.8.4. Strategic initiatives
8.3.9. 21 st Century Medicine
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Procedure benchmarking
8.3.9.4. Strategic initiatives
8.3.10. Biolife Solutions
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Procedure benchmarking
8.3.10.4. Strategic initiatives
8.3.11. Teva Pharmaceutical
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Procedure benchmarking
8.3.11.4. Strategic initiatives
8.3.12. Veloxis Pharmaceuticals
8.3.12.1. Company overview
8.3.12.2. Financial performance
8.3.12.3. Procedure benchmarking
8.3.12.4. Strategic initiatives


　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療）の最新刊レポート

Grand View Research社のその他分野での最新刊レポート

本レポートと同じKEY WORD（transplant）の最新刊レポート


よくあるご質問


Grand View Research社はどのような調査会社ですか?


グランドビューリサーチ（Grand View Research）は通信技術、化学品、材料、ヘルスケア、エネルギーなど広範な市場を対象にした調査報告書を出版しています。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/12/20　10:28

158.95 円

165.20 円

201.28 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.